Abstracts: Symposium
- Altered Expression of Phosphodiasterase 4 (PDE4) Variants in Brain of Depressed Subjects: Role in Disease and Treatment
- Antidepressants in the wild
- Applying genetic profiles in clinical practice
- Are chronic fatigue and chronic fatigue syndrome valid clinical entities across countries and healthcare settings?
- B-COS Gender Matters: Presenting the Profile of Females with Bipolar Disorder from an Australian Observational Study
- BDNF and TrkB mRNA Reductions in the Frontal Cortex and Hippocampus in Major Mental Illness may be Reversed by Antidepressants
- BRAVEHEART: Group cognitive behaviour therapy for cardiac depression
- Case examples: The practical use of Quetiapine in Bipolar Disorder
- Chronobiology and sleep physiology in bipolar disorder
- Circadian Rhythms in Bipolar Disorder: Clinical Application of Quetiapine
- Cognitive profiles for comorbid depression and alcohol use disorders: Impact on response to treatment
- Computer-based treatment for comorbid depression and substance use problems: The SHADE project
- Current evidence on the management of comorbid alcohol and depressive disorders
- Depression & the sleep-wake cycle
- Depression and Anxiety Pathway: Diagnosis, Treatment Choice - Illustration from Surrey UK
- Desvenlafaxine Clinical profile
- Disease Burden of Bipolar and Schizoaffective Disorder in an Australian Cohort: Results after 12 months
- From reality of secondary prevention to the hope of primary prevention
- Gene-environment interactions and exon-specific dysregulation of BDNF expression in a transgenic mouse model of depression-like behaviours
- History of illness prior to a diagnosis of Bipolar Disorder or Schizoaffective Disorder
- Integrated vs single-focussed treatment for depression and alcohol use problems: A randomised controlled trial
- Introduction
- Mental health, physical health and substance use among a rural Australian sample
- Neurobiology of Depression
- Pathways of risk for depression: BDNFVal66Met, stress and emotional brain systems
- Quality of Life of Participants with Bipolar and Schizoaffective Disorder in an Australian Cohort: Results After 12 Months
- Relationship of Monoamine Oxidase A Binding Abnormalities to the Development and Maintenance of Major Depressive Disorder
- Rhythm and Blues
- Role of BDNF in behaviour: studies in rats and BDNF mutant mice
- Role of HPA Axis and Cytokines in Adolescent Depression and Suicide: A Postmortem Brain Study
- Role of the circadian and sleep systems in the management of bipolar disorder
- The Circadian System
- The depressive journey: a model of addressing the risk and disability over time
- The effectiveness of CBT for depression and substance use compared to standard care among young people with co-occurring depression/anxiety and substance use
- The involvement of neurotransmitter receptors and pro-inflammatory pathways in depression
- Treatment of depression and alcohol problems by remote delivery
- Truth, Politics and Intellectual Disability
- Understanding depression in Parkinson’s Disease
- Why hypnosis is particularly useful in treating anxiety disorders
39 abstracts